Patents Assigned to MEDCURA, INC
  • Patent number: 11787922
    Abstract: Disclosed herein is a polymer composition comprising an effective amount of a hydrophobically-modified polymer having functional groups along the backbone occupied by a fatty anhydride moiety. The polymer composition has a potent hemostatic action by gelling blood upon contact, and is suitable for treating internal and external bleeds. As disclosed herein, the modified polymer can be generated without the use of toxic reagents that would require removal from the product. Further, compositions are shelf stable even in a flowable form. That is, the hydrophobic grafts are not lost under product storage conditions (e.g., room temperature storage).
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: October 17, 2023
    Assignee: Medcura, Inc.
    Inventor: Matthew Dowling
  • Patent number: 11274194
    Abstract: Disclosed herein is a polymer composition comprising an effective amount of a hydrophobically-modified polymer having functional groups along the backbone occupied by a fatty anhydride moiety. The polymer composition has a potent hemostatic action by gelling blood upon contact, and is suitable for treating internal and external bleeds. As disclosed herein, the modified polymer can be generated without the use of toxic reagents that would require removal from the product. Further, compositions are shelf stable even in a flowable form. That is, the hydrophobic grafts are not lost under product storage conditions (e.g., room temperature storage).
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: March 15, 2022
    Assignee: MEDCURA, INC
    Inventor: Matthew Dowling